VAD-C Ventricular Assist Device
Certification Practice Exam 2026–2027 –
Real Questions & Detailed Rationales |
Advanced Cardiac Nursing & Perfusion Prep
VAD-C Ventricular Assist Device Certification Practice Exam 2026–2027
• This practice exam contains 200 carefully crafted questions with detailed EXPERT
RATIONALEs designed to mirror the real VAD-C certification exam — use it by
attempting each question independently before revealing the correct answer and
EXPERT RATIONALE to reinforce active recall and deepen your clinical
understanding.
• Features include bolded questions and correct answers, A–E multiple choice
format, one option per line, and evidence-based EXPERT RATIONALE to help you
master VAD physiology, device management, alarms, anticoagulation,
complications, and patient care.
1. What is the primary purpose of a Ventricular Assist Device (VAD)?
A. To replace the heart permanently in all patients
B. To administer intravenous medications continuously
C. To provide oxygen directly to the lungs
D. To monitor cardiac output only
E. To perform electrical cardioversion
C. To provide mechanical circulatory support to a failing ventricle
EXPERT RATIONALE: A VAD mechanically unloads a failing ventricle and maintains
systemic or pulmonary perfusion. It does not replace the heart but supplements its
function, serving as a bridge to transplant, recovery, or destination therapy.
2. Which ventricle does a Left Ventricular Assist Device (LVAD) primarily
support?
,A. Right ventricle
B. Both ventricles equally
C. The atria
D. The pulmonary ventricle
E. Neither ventricle
B. Left ventricle
EXPERT RATIONALE: An LVAD draws blood from the left ventricle via an inflow cannula
and pumps it into the aorta, bypassing the weakened left ventricle and maintaining
systemic circulation.
3. Which of the following is a common indication for LVAD implantation?
A. Hypertensive emergency
B. Pulmonary embolism
C. End-stage heart failure refractory to medical therapy
D. Atrial fibrillation with rapid ventricular response
E. Acute asthma exacerbation
C. End-stage heart failure refractory to medical therapy
EXPERT RATIONALE: LVADs are indicated when patients with advanced heart failure no
longer respond to optimal medical therapy, serving as a bridge to transplant (BTT),
bridge to candidacy (BTC), or destination therapy (DT).
4. What does the term "destination therapy" mean in the context of VAD
support?
A. Temporary support until recovery
B. Support until a donor heart is available
,C. Permanent mechanical support for patients ineligible for transplant
D. Short-term support post cardiac surgery
E. Support during cardiac rehabilitation only
C. Permanent mechanical support for patients ineligible for transplant
EXPERT RATIONALE: Destination therapy refers to the long-term or permanent use of a
VAD in patients who are not candidates for heart transplantation, with the device
intended as the final treatment.
5. Which parameter is most directly monitored to assess LVAD function?
A. Serum potassium
B. Urine output alone
C. Flow, speed (RPM), power, and pulsatility index
D. Chest X-ray findings only
E. Body temperature
C. Flow, speed (RPM), power, and pulsatility index
EXPERT RATIONALE: LVAD function is assessed through device parameters including
pump speed (RPM), estimated flow (L/min), power consumption (watts), and pulsatility
index (PI), which together reflect hemodynamic performance and native cardiac
contribution.
6. The pulsatility index (PI) on an LVAD controller reflects:
A. The patient's blood pressure reading
B. The degree of native ventricular contractile contribution
C. The oxygen saturation of the blood
D. The temperature of the pump
, E. The anticoagulation level
B. The degree of native ventricular contractile contribution
EXPERT RATIONALE: PI measures the variation in pump flow over the cardiac cycle. A
higher PI indicates more native heart contractility contributing to flow, while a low PI
may suggest poor native function or suction events.
7. What is the most common long-term complication of LVAD therapy?
A. Pulmonary hypertension
B. Renal failure
C. Gastrointestinal bleeding
D. Pneumonia
E. Deep vein thrombosis
C. Gastrointestinal bleeding
EXPERT RATIONALE: GI bleeding is the most common long-term complication in LVAD
patients, largely due to acquired von Willebrand factor deficiency caused by high shear
stress in continuous-flow pumps, combined with mandatory anticoagulation therapy.
8. Acquired von Willebrand syndrome in LVAD patients occurs due to:
A. Excessive heparin use
B. Autoimmune destruction of platelets
C. High shear stress causing degradation of vWF multimers
D. Liver failure reducing clotting factor synthesis
E. Nutritional deficiency of Vitamin K
C. High shear stress causing degradation of vWF multimers
Certification Practice Exam 2026–2027 –
Real Questions & Detailed Rationales |
Advanced Cardiac Nursing & Perfusion Prep
VAD-C Ventricular Assist Device Certification Practice Exam 2026–2027
• This practice exam contains 200 carefully crafted questions with detailed EXPERT
RATIONALEs designed to mirror the real VAD-C certification exam — use it by
attempting each question independently before revealing the correct answer and
EXPERT RATIONALE to reinforce active recall and deepen your clinical
understanding.
• Features include bolded questions and correct answers, A–E multiple choice
format, one option per line, and evidence-based EXPERT RATIONALE to help you
master VAD physiology, device management, alarms, anticoagulation,
complications, and patient care.
1. What is the primary purpose of a Ventricular Assist Device (VAD)?
A. To replace the heart permanently in all patients
B. To administer intravenous medications continuously
C. To provide oxygen directly to the lungs
D. To monitor cardiac output only
E. To perform electrical cardioversion
C. To provide mechanical circulatory support to a failing ventricle
EXPERT RATIONALE: A VAD mechanically unloads a failing ventricle and maintains
systemic or pulmonary perfusion. It does not replace the heart but supplements its
function, serving as a bridge to transplant, recovery, or destination therapy.
2. Which ventricle does a Left Ventricular Assist Device (LVAD) primarily
support?
,A. Right ventricle
B. Both ventricles equally
C. The atria
D. The pulmonary ventricle
E. Neither ventricle
B. Left ventricle
EXPERT RATIONALE: An LVAD draws blood from the left ventricle via an inflow cannula
and pumps it into the aorta, bypassing the weakened left ventricle and maintaining
systemic circulation.
3. Which of the following is a common indication for LVAD implantation?
A. Hypertensive emergency
B. Pulmonary embolism
C. End-stage heart failure refractory to medical therapy
D. Atrial fibrillation with rapid ventricular response
E. Acute asthma exacerbation
C. End-stage heart failure refractory to medical therapy
EXPERT RATIONALE: LVADs are indicated when patients with advanced heart failure no
longer respond to optimal medical therapy, serving as a bridge to transplant (BTT),
bridge to candidacy (BTC), or destination therapy (DT).
4. What does the term "destination therapy" mean in the context of VAD
support?
A. Temporary support until recovery
B. Support until a donor heart is available
,C. Permanent mechanical support for patients ineligible for transplant
D. Short-term support post cardiac surgery
E. Support during cardiac rehabilitation only
C. Permanent mechanical support for patients ineligible for transplant
EXPERT RATIONALE: Destination therapy refers to the long-term or permanent use of a
VAD in patients who are not candidates for heart transplantation, with the device
intended as the final treatment.
5. Which parameter is most directly monitored to assess LVAD function?
A. Serum potassium
B. Urine output alone
C. Flow, speed (RPM), power, and pulsatility index
D. Chest X-ray findings only
E. Body temperature
C. Flow, speed (RPM), power, and pulsatility index
EXPERT RATIONALE: LVAD function is assessed through device parameters including
pump speed (RPM), estimated flow (L/min), power consumption (watts), and pulsatility
index (PI), which together reflect hemodynamic performance and native cardiac
contribution.
6. The pulsatility index (PI) on an LVAD controller reflects:
A. The patient's blood pressure reading
B. The degree of native ventricular contractile contribution
C. The oxygen saturation of the blood
D. The temperature of the pump
, E. The anticoagulation level
B. The degree of native ventricular contractile contribution
EXPERT RATIONALE: PI measures the variation in pump flow over the cardiac cycle. A
higher PI indicates more native heart contractility contributing to flow, while a low PI
may suggest poor native function or suction events.
7. What is the most common long-term complication of LVAD therapy?
A. Pulmonary hypertension
B. Renal failure
C. Gastrointestinal bleeding
D. Pneumonia
E. Deep vein thrombosis
C. Gastrointestinal bleeding
EXPERT RATIONALE: GI bleeding is the most common long-term complication in LVAD
patients, largely due to acquired von Willebrand factor deficiency caused by high shear
stress in continuous-flow pumps, combined with mandatory anticoagulation therapy.
8. Acquired von Willebrand syndrome in LVAD patients occurs due to:
A. Excessive heparin use
B. Autoimmune destruction of platelets
C. High shear stress causing degradation of vWF multimers
D. Liver failure reducing clotting factor synthesis
E. Nutritional deficiency of Vitamin K
C. High shear stress causing degradation of vWF multimers
